188 related articles for article (PubMed ID: 27018197)
1. Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest.
Ali AM; Mirrakhimov AE; Abboud CN; Cashen AF
Hematol Oncol; 2016 Jun; 34(2):69-78. PubMed ID: 27018197
[TBL] [Abstract][Full Text] [Related]
2. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
[TBL] [Abstract][Full Text] [Related]
3. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
[TBL] [Abstract][Full Text] [Related]
4. Leukocytoreduction for acute leukemia.
Porcu P; Farag S; Marcucci G; Cataland SR; Kennedy MS; Bissell M
Ther Apher; 2002 Feb; 6(1):15-23. PubMed ID: 11886572
[TBL] [Abstract][Full Text] [Related]
5. Hyperleukocytosis and leukostasis in acute and chronic leukemias.
Macaron W; Sargsyan Z; Short NJ
Leuk Lymphoma; 2022 Aug; 63(8):1780-1791. PubMed ID: 35357988
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.
Tan D; Hwang W; Goh YT
Ann Acad Med Singap; 2005 Apr; 34(3):229-34. PubMed ID: 15902342
[TBL] [Abstract][Full Text] [Related]
7. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S
Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
[TBL] [Abstract][Full Text] [Related]
8. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
[TBL] [Abstract][Full Text] [Related]
9. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management.
Porcu P; Cripe LD; Ng EW; Bhatia S; Danielson CM; Orazi A; McCarthy LJ
Leuk Lymphoma; 2000 Sep; 39(1-2):1-18. PubMed ID: 10975379
[TBL] [Abstract][Full Text] [Related]
10. Leukostasis in Chronic Lymphocytic Leukemia.
Singh N; Singh Lubana S; Dabrowski L; Sidhu G
Am J Case Rep; 2020 Jul; 21():e924798. PubMed ID: 32616708
[TBL] [Abstract][Full Text] [Related]
11. Hyperleukocytosis and leukostasis: management of a medical emergency.
Giammarco S; Chiusolo P; Piccirillo N; Di Giovanni A; Metafuni E; Laurenti L; Sica S; Pagano L
Expert Rev Hematol; 2017 Feb; 10(2):147-154. PubMed ID: 27967252
[TBL] [Abstract][Full Text] [Related]
12. Rapid Fire: Acute Blast Crisis/Hyperviscosity Syndrome.
Emerson G; Kaide CG
Emerg Med Clin North Am; 2018 Aug; 36(3):603-608. PubMed ID: 30037446
[TBL] [Abstract][Full Text] [Related]
13. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP; Zeidan AM
Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary leukostasis: role of perfusion lung scan in diagnosis and follow up.
Szyper-Kravitz M; Strahilevitz J; Oren V; Lahav M
Am J Hematol; 2001 Jun; 67(2):136-8. PubMed ID: 11343387
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia.
De Santis GC; de Oliveira LC; Romano LG; Almeida Prado Bde P; Simoes BP; Rego EM; Covas DT; Falcao RP
J Clin Apher; 2011; 26(4):181-5. PubMed ID: 21574176
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Leukocytapheresis to relieve priapism due to leukostasis in CML patients: Our experience in a tertiary care centre.
Sil S; Mohan AK; Negi G; Banerjee P; Kaur D; Mittal A; Jain A
Transfus Clin Biol; 2024 Feb; 31(1):36-40. PubMed ID: 37944664
[TBL] [Abstract][Full Text] [Related]
17. [Leukapheresis in children with chronic myeloid leukemia and pulmonary leukostasis].
Bubała H; Sońta-Jakimczyk D; Janik-Moszant A; Szczepański T; Tomaszewska R; Drybańska B; Sierantowicz-Zdaniewicz U; Frankiewicz E
Pol Merkur Lekarski; 2004 Nov; 17(101):500-2. PubMed ID: 15754643
[TBL] [Abstract][Full Text] [Related]
18. Reduced tumor lysis syndrome with low dose chemotherapy for hyperleukocytic acute leukemia prior to induction therapy.
Liang R; Bai QX; Zhang YQ; Zhang T; Yang L; Wang YW; Zhu HF; Wang WQ; Gu HT; Gao GX; Shu MM; Chen XQ
Asian Pac J Cancer Prev; 2011; 12(7):1807-11. PubMed ID: 22126570
[TBL] [Abstract][Full Text] [Related]
19. Leukostasis retinopathy: An uncommon visual threatening complication of chronic myeloid leukemia with severe hyperleukocytosis - A case report and review of the literature.
Chen B; Yan X; Zhang X; Yang H
Indian J Ophthalmol; 2018 Dec; 66(12):1871-1874. PubMed ID: 30451209
[TBL] [Abstract][Full Text] [Related]
20. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
[No Abstract] [Full Text] [Related]
[Next] [New Search]
